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Figure S1. Stronger Selective Pressure Affecting the Wobble Positions when Comparing 
Human against Eight Different Species in Alternatively Spliced Exons compared to 
Constitutively Spliced Ones  
 
The conserved orthologous exons of 8 species (including mouse) were extracted and the 
exon pairs were aligned. Conservation level of each coding position between human and 
a given species in (A) constitutively spliced exons and (B) in alternatively spliced exons. 
X axis, the species that were aligned against human; Y axis, conservation level of each 
exonic position between human and the indicated species; Z axis, the positions of the 
codon. 
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Figure S2. Exon Length Affects the Conservation Level of the Wobble Positions 
 
The exons were divided to subgroups according to their length, and the conservation level 
of wobble positions was examined. The 'short' and 'long' exons subgroups were defined 
as (A) the bottom and top 25% of the alternatively (left panel) and constitutively (right 
panel) spliced exons (for each spliced exons separately). (B) Similar to A, except that the 
definition of 'long' and 'short' exons is according to the bottom and top 25% of the 
constitutively spliced exons. X axis for both panels is the location range from the 3'ss to 
the 5'ss, in 10% increments (exons are normalized between 0 and 1, see Experimental 
Procedures); Y axis is the conservation level of the wobble positions between conserved 
human-mouse orthologous exons. 
 
  3
 
 
 
 
Figure S3. The Distribution of all the 285 Putative ESRs along the Exons 
 
The distribution of the 285 ESRs along alternative (left panel) and constitutive (right 
panel) exons. X axis is the location range from the 3'ss to the 5'ss, in 10% increments 
(exons are normalized between 0 and 1, see Experimental Procedures); Y axis, % of the 
candidates' appearance in the tenth which was defined as the number of appearances of 
all the candidates in the tenth divided by the total amount of appearances of those chosen 
candidates in all the exons.  4
Table S1. The Human Codon Usage and Codon Conservation Table  
 
Column A is the codon sequence, Column B is the one letter amino acid abbreviation of 
the codon, Column C is the number of occurrences of the codon in the human exons 
(alternative and constitutive together). Column D is the average occurrence in 1000 
codons. Column E is the relative frequency of each codon with respect to its amino-acid 
class, i.e., the occurrence of the codon out of the occurrences of all codons coding for the 
same amino acid.  Column F is the number of codons that were conserved (computed as 
described above). Column G is the percentage of conserved codon (F/C×100). 
 
F = Frequency of usage of each codon (per thousand). 
RF = relative frequency of each codon among synonymous codons. 
 
 
A B  C  D  E  F  G  
Codon 
Amino 
Acid  Occurrence F RF Conserved %  conservation 
GCC A  42370 25  0.39  30371  71.68% 
GCA A  27141 16.01  0.25  17940  66.10% 
GCG A  7429 4.38  0.07 1773  23.87% 
GCT A  31528 18.6  0.29 21356  67.74% 
TGT C  19882 11.73  0.47  15324  77.07% 
TGC C  22051 13.01  0.53  17033  77.24% 
GAC D  46444 27.4  0.51 35501  76.44% 
GAT D  44348 26.17  0.49  30981  69.86% 
GAG E  69058 40.75  0.55  54457  78.86% 
GAA E  56756 33.49  0.45  39606  69.78% 
TTT F  35623 21.02  0.49  27226  76.43% 
TTC F  37152 21.92  0.51  30880  83.12% 
GGA G  30865 18.21  0.29  21714  70.35% 
GGT G  16672 9.84  0.16  9783  58.68% 
GGG G  24473 14.44  0.23  15599  63.74% 
GGC G  33961 20.04  0.32  25117  73.96% 
CAC H  25415 15  0.56  19228  75.66% 
CAT H  19649 11.59  0.44  12787  65.08% 
ATC I  38978 23  0.47  31144  79.90% 
ATT I  31838 18.79  0.38  22231  69.83% 
ATA I  12981 7.66  0.15  9307  71.70% 
AAG K  58350 34.43  0.57  49852  85.44% 
AAA K  44856 26.47  0.43  32600  72.68% 
CTG L  62750 37.03  0.39  49956  79.61% 
CTC L  32887 19.41  0.21  23359  71.03% 
TTG L  15695 9.26  0.1  13546  86.31% 
CTT L  25352 14.96  0.16  15951  62.92% 
TTA L  11683 6.89  0.07  8833  75.61% 
CTA L  12000 7.08  0.07  4851  40.42% 
ATG M  38032 22.44 1  37171  97.74% 
AAC N  34394 20.29  0.52  27420  79.72% 
AAT N  31444 18.55  0.48  22032  70.07%  5
CCG P  7665 4.52  0.08 1898  24.76% 
CCA P  28238 16.66  0.3  19543  69.21% 
CCC P  28431 16.78  0.3  18359  64.57% 
CCT P  29192 17.23  0.31  20088  68.81% 
CAG Q  61593 36.34  0.74  53986  87.65% 
CAA Q  21816 12.87  0.26  13191  60.46% 
CGA R  10924 6.45  0.13  6502  59.52% 
AGA R  17396 10.26  0.21  13966  80.28% 
CGC R  15473 9.13  0.19 10113  65.36% 
AGG R  13634 8.04  0.17 10656  78.16% 
CGT R  8007 4.72  0.1  4147  51.79% 
CGG R  16409 9.68  0.2  11387  69.39% 
AGT S  18762 11.07  0.15  13352  71.17% 
AGC S  27611 16.29  0.23  22396  81.11% 
TCG S  5697 3.36  0.05 1425  25.01% 
TCA S  19455 11.48  0.16  12646  65.00% 
TCC S  26519 15.65  0.22  18675  70.42% 
TCT S  24015 14.17  0.2  16573  69.01% 
ACA T  26611 15.7  0.31 18177  68.31% 
ACC T  29839 17.61  0.34  21027  70.47% 
ACG T  9492 5.6  0.11  2678  28.21% 
ACT T  21190 12.5  0.24 12839  60.59% 
GTG V  49018 28.92  0.47  39379  80.34% 
GTT V  19427 11.46  0.19  12428  63.97% 
GTA V  12527 7.39  0.12  5736  45.79% 
GTC V  23758 14.02  0.23  17613  74.14% 
TGG W  24244 14.31 1  24192  99.79% 
TAC Y  30058 17.74  0.54  23490  78.15% 
TAT Y  25687 15.16  0.46  17431  67.86%  6
Table S2. List of 285 Putative ESRs Identified by the Bioinformatic Analysis, in which 
the p Value Is Statistically Significant for Both Prevalence and Conservation in the 
Wobble Positions 
 
Hexamer P(prevalence) P(conservation)
GATGAA <  2.70735E-264  2.31E-28 
CTCATC  < 2.70735E-264   1.50E-12 
ACCATC 2.71E-264  8.18E-27 
AATGAA 2.57E-253  1.23E-23 
CTCTTC 1.54E-250  9.61E-19 
CTGGAG 9.38E-234  5.18E-11 
TTTGAA 1.48E-223  1.14E-55 
GCCATC 8.32E-216  2.54E-17 
GTCATC 4.63E-211  1.11E-16 
CCCATC 5.33E-203  1.49E-10 
GCCAAG 7.38E-177  1.23E-37 
TTTGAT 6.41E-175  4.90E-31 
TATGAA 6.05E-172  2.96E-25 
ACCAAG 6.91E-168  1.40E-16 
TTTGGA 1.32E-157  1.59E-27 
GGCTGC 1.51E-154  2.02E-09 
CCCAAC 4.53E-154  9.28E-14 
ATTGAA 8.56E-143  4.89E-18 
TTTGCT 5.33E-140  1.30E-22 
GGCTGG 3.19E-135  1.90E-13 
GGCTAC 4.54E-135  3.82E-09 
ACCAAC 4.28E-134  1.01E-19 
TGTGAA 5.38E-134  5.35E-10 
CTCACC 1.34E-132  1.33E-08 
CCCAGC 8.21E-131  3.38E-16 
AATGGA 1.92E-128  5.95E-13 
GATGCT 4.81E-126  2.68E-12 
GCTGTG 2.97E-124  7.89E-08 
GATGAC 2.42E-121  3.64E-09 
GCCATG 4.83E-121  3.36E-23 
GAAGAA 2.82E-116  1.82E-21 
GTCACC 1.59E-114  3.25E-07 
GCAGAA 3.98E-113  3.85E-07 
TGTGAC 1.69E-112  4.76E-18 
GCCAAC 5.52E-108  2.38E-18 
GAAGAT 7.97E-108  1.65E-15 
CAAGAA 6.40E-106  1.47E-23 
GCCACC 1.15E-105  7.50E-10 
AAAGGA 4.36E-104  2.64E-09 
TTTGAG 3.68E-103  1.79E-08 
CTCAAC 8.91E-103  1.13E-14 
CCCAAG 9.31E-103  2.91E-23 
ATCATC 8.96E-102  1.87E-11 
GCCTTC 5.84E-101  1.50E-11 
TCAGAA 3.34E-100  1.20E-09  7
GGAGAA 4.84E-100  1.52E-12 
ATAGAA 1.98E-97  1.66E-13 
ATTGGA 8.12E-97  4.77E-14 
TTCTTC 9.77E-96  7.05E-14 
ACCTTC 4.18E-94  1.00E-09 
CATGAA 6.09E-93  3.35E-11 
AGTGAA 7.07E-92  2.22E-07 
TCCATC 7.56E-92  2.95E-15 
CGCTGG 3.81E-91  3.84E-09 
AGTGAC 8.35E-90  8.29E-08 
ATTGCT 2.53E-88  2.62E-06 
GTAGAA 8.03E-88  3.44E-07 
GCAGAT 1.72E-87  1.70E-06 
ACCATG 4.12E-87  1.48E-14 
TTTGCC 1.44E-86  1.79E-07 
GACAGC 2.41E-85  9.60E-07 
GATGCC 9.73E-85  5.20E-09 
GGCATC 3.27E-84  5.11E-07 
GACTGG 1.05E-83  4.80E-14 
TCCATG 8.14E-83  2.80E-10 
TATGGA 6.05E-81  8.25E-11 
GATGTT 6.87E-81  6.74E-07 
TCCTTC 7.40E-81  4.56E-09 
TTTGAC 1.50E-79  5.17E-11 
AAAGAA 1.71E-79  1.40E-07 
ACCTAC 4.98E-79  1.21E-08 
TTCATC 2.33E-78  1.16E-08 
AATGAC 2.72E-78  9.72E-16 
GGGAAG 9.06E-78  8.22E-08 
CCCATG 3.83E-76  5.13E-19 
GATGCA 5.81E-75  2.20E-08 
GATGGA 9.08E-75  1.25E-11 
CCCTGC 1.20E-74  1.18E-09 
TTTGTG 1.43E-74  5.06E-10 
TCAGAT 1.94E-74  3.64E-07 
GACATG 2.83E-74  1.71E-17 
CAAGGA 3.75E-74  1.90E-23 
TATGAC 1.21E-73  2.23E-14 
AATGCA 4.56E-72  1.56E-09 
ATTGAT 6.49E-72  3.05E-11 
GACATC 7.80E-72  5.04E-12 
GAAGTT 1.81E-71  1.15E-11 
TTTGGG 7.08E-71  3.24E-10 
GAGAAG 7.54E-69  1.10E-16 
GTTGGA 1.62E-68  3.37E-11 
TGTGAG 5.88E-68  3.12E-07 
GCCAGC 2.04E-67  8.63E-16 
GTCAGC 2.92E-67  5.82E-10 
CCCTTC 3.98E-67  5.26E-07 
TTTGCA 4.22E-67  1.96E-15  8
AATGCT 7.85E-67  7.01E-09 
TATGCA 2.33E-65  2.33E-13 
CTTGGA 5.09E-65  3.46E-09 
TTTGTT 5.39E-65  1.86E-07 
TGTGCC 5.47E-65  1.18E-06 
TTCCAG 9.08E-65  4.16E-08 
GCTGCT 1.11E-64  1.96E-14 
TTTGGT 2.01E-64  1.67E-09 
ATCACC 6.10E-64  4.06E-09 
ACTGGA 5.38E-63  1.55E-15 
GATGGC 1.19E-62  4.64E-07 
AGCATC 1.48E-61  2.83E-13 
AACAGC 6.60E-61  4.02E-11 
GTTGGT 1.20E-60  3.65E-09 
GTCTTC 6.82E-59  2.01E-13 
CCTGGA 8.03E-59  3.63E-10 
TTGGAT 1.76E-58  7.30E-08 
AATGCC 1.97E-58  7.67E-08 
GAAGTA 2.46E-58  1.87E-07 
GACAAG 5.45E-58  4.96E-11 
AACATC 4.55E-57  1.46E-08 
TACATC 8.46E-57  2.81E-06 
ATCAAC 1.54E-56  1.17E-11 
TTCTCC 1.60E-56  2.57E-08 
TGTGCT 4.42E-56  5.70E-06 
TGTGTG 7.49E-56  4.22E-06 
ATTGGT 1.05E-55  7.04E-08 
GCTGCC 1.06E-55  2.21E-09 
GGCTGT 7.74E-55  4.50E-07 
CTAGAA 1.11E-54  3.31E-15 
CAAGTA 1.56E-54  6.90E-08 
GATGGT 5.73E-54  6.25E-06 
TTCCTG 7.09E-54  3.22E-09 
ACCAGC 8.23E-54  4.98E-12 
GACAAC 1.17E-53  3.02E-13 
GCCTGC 1.67E-53  7.26E-09 
TTAGAA 3.51E-53  2.61E-11 
CAAGAT 4.87E-53  1.72E-11 
GACTTC 1.03E-52  3.63E-09 
AGAGAA 5.86E-52  3.35E-07 
TATGAG 7.90E-52  8.77E-10 
ATTTTA 1.44E-51  3.45E-06 
TTCATG 3.10E-51  4.48E-09 
AGTGGT 3.38E-51  7.82E-07 
AACAAC 3.97E-51  4.93E-10 
CTCATG 5.99E-51  5.52E-14 
TCTGCA 2.44E-50  7.94E-10 
ACAGAA 2.59E-50  9.70E-12 
TACCTG 3.39E-50  4.86E-15 
GAAGGA 7.66E-50  8.65E-11  9
TCTGTG 1.09E-49  5.98E-10 
AAAGTA 1.20E-48  5.04E-07 
ATCATG 4.89E-48  1.41E-13 
CTTCCT 5.22E-48  3.79E-11 
TACTGC 6.00E-47  1.24E-08 
TTAAAT 1.06E-46  1.94E-08 
GAAAAT 5.56E-46  3.31E-07 
GACCAG 1.03E-45  2.01E-12 
CGCCTG 3.99E-45  1.20E-07 
GATGTC 7.15E-45  4.72E-07 
TCCTGG 7.82E-45  3.18E-08 
ATATTT 1.01E-43  4.57E-13 
TTCAAC 4.53E-43  2.19E-06 
GGTGGA 9.51E-43  1.98E-07 
AACTTC 1.05E-42  7.19E-07 
GCAGAG 1.56E-42  1.72E-06 
GCTGTT 2.82E-42  4.90E-06 
AAGAAG 3.30E-42  7.18E-06 
GACCTG 5.18E-42  2.37E-09 
GGTGCT 1.05E-41  3.92E-11 
CACATG 1.13E-41  4.16E-11 
CCAGAA 2.94E-41  2.78E-08 
CCCTAC 6.46E-41  7.35E-07 
GGAGGA 2.57E-40  2.32E-09 
AGTGCC 2.04E-39  1.56E-06 
GCCTGG 2.24E-39  5.07E-12 
CAAGTT 2.27E-39  6.55E-08 
AACTGG 3.94E-39  1.68E-10 
AACATG 9.63E-39  2.48E-08 
TCTGGA 1.38E-38  2.76E-13 
GTCATG 3.41E-38  8.85E-09 
TTCCGG 8.70E-38  4.56E-08 
TTCTGG 1.02E-37  8.51E-07 
TTCTGC 1.95E-37  3.05E-06 
GCTGGT 3.10E-37  2.68E-07 
TTTGTA 4.28E-37  2.58E-08 
ATCTTC 1.00E-36  6.61E-10 
AAAGAT 3.74E-36  1.75E-06 
TACATG 8.84E-36  2.61E-11 
TGTGGC 1.14E-35  1.73E-06 
GCGGCG 3.69E-35  1.37E-07 
TGTGCA 1.18E-34  1.35E-08 
AACCTC 1.18E-34  7.01E-06 
AAAGCA 2.74E-34  3.25E-06 
ATTGTA 2.97E-34  4.51E-06 
ACTGTG 1.26E-33  4.59E-06 
CATGCA 5.01E-33  2.28E-06 
TACTGG 6.69E-33  5.05E-09 
TACAAC 8.52E-33  4.22E-06 
TCTGTT 3.34E-32  5.49E-06  10
TGCTGG 6.89E-32  1.05E-09 
GCCTTG 1.73E-31  7.62E-06 
CACTGG 2.32E-31  4.57E-11 
GACCTC 2.56E-31  6.63E-11 
AATGGT 2.56E-31  2.75E-07 
GTTCTT 4.70E-31  1.56E-06 
TGTGTC 7.44E-31  6.55E-09 
CAAGCA 6.65E-30  4.37E-06 
TCAGGA 2.25E-29  2.30E-06 
ATCAGC 7.47E-29  1.66E-09 
AGTGCT 1.03E-28  1.12E-06 
TTGGCA 4.57E-28  7.87E-07 
GGAAGA 4.65E-28  4.02E-08 
CTTGTT 1.76E-27  7.90E-07 
GTCTAC 3.00E-27  2.32E-06 
CAAAGA 6.45E-27  4.34E-06 
CCAGGA 8.56E-27  1.32E-10 
TCCAAG 9.71E-27  2.95E-10 
GCTGCA 1.63E-26  1.34E-07 
AGAGGA 1.63E-26  3.83E-06 
ATCTGC 2.68E-26  1.62E-09 
TACCAG 4.84E-26  7.17E-08 
CCTGGT 5.67E-26  1.83E-06 
AGCTAC 6.43E-26  1.55E-07 
CCCAAA 1.44E-25  4.00E-11 
TATGGG 1.63E-25  3.07E-06 
CACAAG 1.96E-25  2.69E-11 
ACTGCA 5.86E-25  5.87E-08 
GCCATT 1.16E-24  4.18E-10 
CACAAC 1.68E-24  2.30E-06 
CAAGCT 9.59E-24  4.55E-11 
ACCAAA 2.07E-23  1.30E-14 
TATGTA 2.10E-23  4.11E-06 
TCTGTC 2.61E-23  3.77E-06 
GGAGCA 7.26E-23  1.42E-08 
ATCTAC 3.08E-22  1.37E-07 
TCTGGG 3.24E-22  2.01E-06 
GGTGAA 4.17E-22  2.06E-09 
AGCAAA 5.53E-22  5.70E-09 
ATCCAG 6.17E-22  6.44E-07 
CTAAAT 8.48E-22  1.07E-07 
AAGAAA 1.04E-21  8.97E-09 
CGAGAA 1.52E-21  9.94E-07 
AATGTA 2.37E-21  8.18E-08 
AACCAG 2.47E-21  1.61E-08 
TACTTC 9.41E-21  2.48E-07 
GTTGTT 2.01E-20  3.83E-07 
TTCAAG 3.79E-20  9.84E-10 
AGTGCA 4.92E-20  1.21E-07 
GACTAC 4.99E-20  7.70E-10  11
ACTGTA 1.26E-19  6.48E-07 
GGCATG 1.66E-19  1.25E-14 
GTGAAG 2.85E-19  1.05E-11 
CGAGGA 1.87E-18  4.17E-07 
AACCTG 2.56E-18  7.08E-08 
AACTAC 1.05E-17  5.92E-08 
TACAAG 3.51E-17  2.99E-06 
ATCAAG 2.27E-16  6.92E-13 
CCCAGG 4.15E-16  2.05E-06 
GACAGA 6.03E-16  3.19E-09 
CCCAGT 2.60E-15  2.92E-07 
CTCAAG 2.67E-15  5.11E-07 
CGTGGT 6.04E-15  2.30E-08 
AGCAAG 4.98E-14  4.05E-11 
TCTGGT 1.04E-12  2.68E-07 
GTTGCT 3.12E-12  3.48E-08 
CTGAAG 4.27E-12  2.78E-06 
GAAGCA 7.83E-12  2.87E-06 
CTTGCT 8.77E-12  3.28E-06 
GTAGCT 1.48E-11  9.93E-09 
TCCTGT 1.94E-11  6.94E-06 
TGCAAA 4.32E-11  1.72E-08 
TCCAAA 4.84E-11  1.52E-06 
CTAGAT 1.22E-10  7.06E-09 
TTAATT 1.22E-10  3.38E-07 
TACTAC 2.42E-10  4.27E-07 
AGCATG 3.07E-10  1.34E-08 
GCAAGA 1.70E-09  9.08E-07 
CTTGTA 3.76E-09  2.62E-07 
TTGGTT 6.09E-09  1.57E-06 
CGCCAG 3.49E-08  6.26E-06 
GCCAAA 1.11E-07  4.80E-12 
CAAGTG 4.58E-07  2.43E-08 
TACCTC 9.96E-07  2.48E-13 
GCAAAT 1.03E-06  9.67E-09 
CCAAAT 1.20E-06  6.35E-09 
CGGAAG 2.56E-06  4.25E-06 
GGCAAC 3.29E-06  1.72E-06 
GCCAGG 1.02E-05  1.94E-06 
TCCAGG 1.66E-05  1.47E-06 
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Table S4  Short group 
1 GAGAAG 
2 AGAGAA 
3 AGAGGA 
4 TTTGGA 
5 AAAGAA 
6 GCAGAT 
7 AATGAA 
8 GCTGCT 
9 AAAGGA 
10 GACAGA 
11 AAGAAA 
12 GATGAA 
13 CAAGAA 
14 ACAGAA 
15 CCTGGA 
16 AGCAAA 
17 CCAGAA 
18 AAGAAG 
19 CAAGGA 
20 CACAAG 
21 GACAAG 
22 GAAGGA 
23 TCAGAA 
24 TCCTGG 
25 AGTGAA 
 
Table S3  5'ss group 
1 AAAGAA 
2 AAGAAG 
3 AAGAAA 
4 GAAGAA 
5 GATGCT 
6 CTGGAG 
7 GATGCC 
8 CCCAGC 
9 CCTGGA 
10 GCCAGC 
11 AGAGGA 
12 GCTGCT 
13 GGAGAA 
14 CCAGGA 
15 TGCTGG 
16 GGAGGA 
17 CAAGAA 
18 GACCTG 
19 GAGAAG 
20 CAAGGA 
21 CAAGCT 
22 TCCTGG 
23 AGAGAA 
24 GCAGAT 
25 CTGAAG 
26 CAAAGA 
Tables S3 and S4. The Sequences of the Putative ESRs Obtained Based on Their 
Prevalence in Alternative Exons with Weak 5′ss and in Short Ones, Respectively 
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Table S5. The Hexamers that Were Chosen for the Experimental Validation and Their 
Characteristics 
 
 
Hexamer      characteristic 
AAAGGA (A)  Weak and near + short 
AAGAAA (B)  Weak and near + short 
CTTGTA (C)  randomly 
TTTGCA (D)  randomly 
TCTGGT (E)  Near 3'ss 
ATCATG (F)  Near 3'ss 
ACTGTA (G)  Near 3'ss 
TATGCA (H)  Near 5'ss 
ATCCAG (I)  Near 5'ss 
CAAGAA (J)  Weak and near + short 
CCCAAG (K)  randomly 
TCCAAA (L)  randomly 
ATCATC (M)  randomly 
GCCAAG (N)  randomly 
 
 
Short = more abundant in short exons compare to long ones. 
Weak = prevalent in alternatively spliced exons with weak 5'ss compared to those with 
strong 5'ss. 
Weak and near = found near the 5'ss in alternatively spliced exons with weak 5'ss. 
Near 3'ss = found in adjacent to the 3'ss in alternatively spliced exons. 
Near 5'ss = found in adjacent to the 5'ss in alternatively spliced exons 
 
The representative letter of each 6-mer appears in parenthesis.  14
Codon Conservation and Occurrence 
From the whole dataset (not including the first base and the last 3 bases of each exon, 
which are part of the 3'ss and 5'ss consensus sequences, respectively), for each one of the 
61 codons (we omitted the 3 stop-codons), we calculated, the codon conservation 
between human and mouse. Specifically, codon that differ in positions other than the 
wobble, were excluded. The score given in our computation is with respect to the human 
codons. Sequences downstream a stop codon, were omitted from the computation. 
Likewise we assemble a codon usage table based on our dataset which contains the 
relative frequency of each of the 61 sense codons (see Table S1 above). To normalize for 
exon length the total number of wobble positions in each exon was divided to ten equal 
length groups from the 3'ss to the 5'ss. 
 
Prediction of Free Energy (∆G) Created by Base-Pairing between Two Short RNA 
Strands 
The prediction of free energy was calculated using the OligoArrayAux 1.9 (Rouillard et 
al., 2002) that was developed by Nick Markham & Michael Zuker at Rensselaer 
Polytechnic Institute, which among other things predicts the free energy (∆G) of a single 
folded RNA strand. To predict the ∆G of two short RNA strands we concatenated these 
strands into one RNA strand as follows: “NN”-Seq1-“NNNNN”-reversed U1 
(UACUUACCUG)-“NN”. Since the software does not hybridize the “N” sequence, 
because it is considered neutral, the resulting calculation of free energy is that of the 
U1:5'ss hybrid. 
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Extracting ESR Subgroups 
We examined the prevalence of the 285 hexamers, which were identified by the 
bioinformatic analysis, in exons found to be under specific selective pressure, namely, in 
alternatively spliced exons with weak 5'ss and in short alternatively spliced exons. Next, 
we selected the 10% most prevalent ESRs for each exon type separately (weak 5'ss, and 
short exons). For each of the chosen ESR groups, we discarded the least prevalent ESRs 
if their level of prevalence was equal to ESRs in the remaining 90% hexamers. The total 
number of chosen ESRs for the weak 5'ss and short alternatively spliced exon groups was 
26 and 25 hexamers, respectively. The chosen ESRs were tested for their distribution 
across the alternatively and constitutively spliced exons (see Tables S3 and S4 above for 
the sequence of the ESRs in each subgroup). We divided each of the alternatively and 
constitutively spliced exons into ten equally sized deciles and examined the distribution 
of the ESRs in the different deciles. The percentage of ESRs that appear in each decile is 
plotted for the weak 5'ss ESRs (Figure 2C) and the short exons (Figure 2D), for the 
constitutively (right panel) and alternatively spliced (left panel) exons, separately (we 
omitted the first nucleotide and the last three nucleotides which are part of the 3'ss and 
the 5'ss consensus sequences, respectively).  
 
Plasmid Constructs 
Oligonucleotide primers were designed to amplify four minigenes: ADAR2 (adenosine 
deaminase) contains the exons 7, 8 and 9; SLC35B3 minigene (solute carrier family 35 
member B3) contains the human genomic sequence from beginning of exon 4 till the end 
of exon 6 (3.1kb), an extensive deletion, of 4350 nucleotides from intron no.4, was done  16
by 2 steps PCR amplification and sub-cloning of the fragments; Talin (TLN ) contains the 
exons 34, 35 and 36 and IMP (IGF-II m-RNA-binding protein) contains exons 10, 11, 12 
and 13.  
Each primer contained an additional sequence encoding a restriction enzyme. The PCR 
products were restriction designed, and they were inserted between the Kpn I–Bgl II sites 
in the pEGFP-C3 plasmid (Clontech). 
 
ESR Insertions 
The list of the 10 ESRs:  
AÆGCAAAGGAAA;  BÆAAAAGAAAGA;  CÆGCCTTGTACA;  DÆCCTTTGCAAT; 
EÆGGTCTGGTTC;  FÆGGATCATGAT;  GÆTGACTGTAAA;  HÆTATATGCAGA; 
IÆAGATCCAGGA;   JÆTTCAAGAATC;  
5' phosphate-oligonucleotide primers complement to the flanking region of the 
substitution containing ESR sequence as a tail in the 5' of the forward oligo were used to 
amplify minigene plasmid with new ESR that did not change the length of the exon. The 
PCR products were treated with 12U DpnI (New England Biolabs) for 1hr at 37
OC. 
Samples were purified by Promega Wizard SV Gel and PCR Clean-Up System. Fifty ng 
of cleaned PCR product than treated with Quick Ligase (New England Biolabs) and the 
ligated plasmid transformed into E.coli XL1 strain, followed by colony-picking miniprep 
and midi-prep extraction (GIBCO/BRL). Cytoplasmic RNA from three different 
transfection experiments was measured both by gel electrophoresis and the intensity of 
the bands were quantitated by ImageJ 1.36 (pixel detection software) and by real-time 
PCR, using the light-cycler detection system (Bio Rad). The ratio of the exon 
inclusion/skipping was about the same by both methods. Each RT-PCR experiment was  17
repeated at least 3 times, and the fluctuation is approximately 8% among the experiments, 
therefore, fluctuations of less than 8% are regarded as non-significant.  
 
Site-Directed Mutagenesis 
A supercoiled double-stranded DNA (dsDNA) vector (pEGFP-C3) with an insert of the 
desirable minigene and two synthetic oligonucleotide primers containing the desired 
mutations and are complementary to opposite strands of the vector, are extended during 
temperature cycling by PfuTurbo DNA polymerase (Stratagene). Incorporation of the 
oligonucleotide primers generates a mutated plasmid containing staggered nicks. The 
PCR programmed for 18 cycles and the elongation time correspond to 2 minute for each 
1kb. The PCR products were treated with 12U DpnI (New England Biolabs) for 1hr at 
37
OC. 1-3µl of the DNA was transformed into E.coli XL1 strain. After transformation, 
the XL1 competent cells repair the nicks in the mutated plasmids to generate the full 
length plasmids. Than perform a colony-picking and mini-prep extraction (GIBCO/BRL). 
All plasmids were confirmed by sequencing. 
 
Transfection and RT-PCR 
Transfection into 293T and HeLa cell lines were cultured in Dulbecco’s Modification of 
Eagle Medium, supplemented with 4.5g/ml glucose (Biological Industries) and 10% fetal 
calf serum, and cultured in 6 wells dish under standard conditions at 37
OC with 5% CO2. 
Cells were grown to 50% confluence, and transfection was performed using FuGENE6 
(Roche) with 1µg of plasmid DNA. RNA isolation was harvested after 48hr. Total 
cytoplasmic RNA was extracted using TriReagent (Sigma), followed by treatment with  18
1U RNase-free DNase (Promega). RT-PCR amplification was preformed for 1hr at 42
oC, 
using oligo dT reverse primer and 2U reverse transcriptase of avian myeloblastosisvirus 
(AMV, Roche). The spliced cDNA products derived from the expressed mini-genes were 
detected by PCR. For amplification of ADAR2 we used identical conditions as in (Lev-
Maor et al., 2003); namely, the pEGFP-specific reverse primer 
(CGCTTCTAACATTCCTATCCAAGCGT) and an exon 7 forward primer 
(CCCAAGCTTTTGTATGTGGTCTTTCTGTTCTGAAG). For SXN13 amplification, we used 
exon 4 reverse primer (GTGGTGAGGCCCTGGGCAGGTC) and exon 1 forward primer 
(AAGGGTAGACCACCAGCAGCCTGGA): Amplification was performed for 30 cycles, 
consisting of 30 sec at 94
OC, 50 sec at 61
OC, and 1 min at 72
OC. The products were 
resolved on 2% agarose gel and confirmed by sequencing. The level of mRNA of the 
house-keeping gene, Glyseraldehyde -3-phosphate dehydrogenase, was used as the 
internal control for each transfection.  
 
 
Reporting Exon Sequences 
The ADAR2 shortened exon 8: 
 
TTTTTTTTTTTTTTTTTTTGAGACAGGGTCTCGCTCTTACACCCAGGCTGGAGTGCAGTGGTGC
AATCATGGCTCGCTGAAGCCCTAAACTCGAGCTGGGACTACAGGCATGT  
(plain and bold fonts indicate intronic and exonic sequences, respectively). 
The α and β positions in figure 6A highlighted in gray, upstream and downstream sites, 
respectively. 
 
  For SLC35B3 and Talin minigenes, the corresponding exon is the middle one of a 
human genomic region containing three exons separated by two introns; IMP is a four- 19
exon minigene separated by three introns, in which the corresponding exon is the third 
one (see also Kol et al., 2005; the sequences of those minigenes are available online: 
http://www.tau.ac.il/~gilast/sup_mat7.htm).  
 
The SLC35B3 (solute carrier family 35, member B3) reporting exon 5 sequence: 
TTTTAAAAATTGTCTTTTACAGAATACCAGGAAAAACCTACATGATAATAGCTTTTCTAACTG
TGGGTACTATGGGGTTATCAAACACTTCCTTGGGCTACCTGAATTACCCTACCCAAGTC
ATCTTCAAGTGCTGCAAATTGATTCCTGTTATGCTAGGAGGAGTTTTTATTCAAGGTATA
G. 
In Figure 4C: C1 refer to substitution of wt hexamer TGAATT with CGCTCT neutral 
sequence; C2 refer to deletion of wt sequence TGAATT; 
In Figure 6B: The ESRs were inserted into two locations (γ and δ, highlighted in gray, 
upstream and downstream sites, respectively). 
 
The Talin reporting exon 35 sequence: 
CAGGTGCTCTCTGCAGCCACCATTGTGGCTAAACACACCTCTGCACTGTGTAACAGCTGT
CGCCTGGCTTCTGCCCGTACCACCAATCCTACTGCCAAGCGCCAGTTTGTACAGTCAGC
CAAGGAGGTGGCCAACAGCACAGCTAATCTTGTCAAGACCATCAAGGTTCCC 
In Figure 4C: C1 refer to substitution of wt heptamer GCACTGT with CAGATCA 
neutral sequence; C2 refer to deletion of wt sequence GCACTGT; C3 refer to 
substitution of wt hexamer GTACCA with CGCTGT neutral sequence; C4 refer to 
substitution of wt hexamer TAATCT with ACTTTT neutral sequence; C5 refer to 
deletion of wt sequence TAATCT.  
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The list of the low-score hexamers: 
L1ÆTATCGATGAG; L2ÆTAATCACGAG; L3ÆTATACCGTAG; L4ÆTATTGTTGAG; 
L5ÆTACGCTCTAG; L6ÆTATCGGGTAG; L7ÆTATTCGAGAG; L8ÆTAGGCGAAAG; 
L9ÆTATTCGATAG;   
Hexamers are marked in bold; the two flanking nucleotides are in plain. 
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